Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Actinogen Medical

Clinical trials sponsored by Actinogen Medical, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill xanamem aims to slow Alzheimer's decline Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New pill xanamem aims to slow Alzheimer's decline

Disease control Ongoing

This study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 10…

Phase 2/3 • Sponsor: Actinogen Medical • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC